Preclinical targeting of aggressive T-cell malignancies using anti-CD5 chimeric antigen receptor
2017
Preclinical targeting of aggressive T-cell malignancies using anti-CD5 chimeric antigen receptor
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
33
References
80
Citations
NaN
KQI